Biology Reference
In-Depth Information
Pizurki L, Zhou Z, Glynos K, Roussos C, Papapetropoulos A (2003) Angiopoietin-1 inhibits
endothelial permeability, neutrophil adherence and IL-8 production. Br J Pharmacol 139:
329-336
Prasain N, Alexeyev M, Balczon R, Stevens T (2009) Soluble adenylyl cyclase-dependent
microtubule disassembly reveals a novel mechanism of endothelial cell retraction. Am J Physiol
Lung Cell Mol Physiol 297:L73-L83
Predescu D, Predescu S, Shimizu J, Miyawaki-Shimizu K, Malik AB (2005) Constitutive eNOS-
derived nitric oxide is a determinant of endothelial junctional integrity. Am J Physiol Lung Cell
Mol Physiol 289:L371-L381
Qiao J, Holian O, Lee BS, Huang F, Zhang J, Lum H (2008) Phosphorylation of GTP dissociation
inhibitor by PKA negatively regulates RhoA. Am J Physiol Cell Physiol 295:C1161-C1168
Qiao J, Huang F, Lum H (2003) PKA inhibits RhoA activation: a protection mechanism against
endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 284:L972-L980
Rahn Landstrom T, Mei J, Karlsson M, Manganiello V, Degerman E (2000) Down-regulation of
cyclic-nucleotide phosphodiesterase 3B in 3T3-L1 adipocytes induced by tumour necrosis
factor alpha and cAMP. Biochem J 346(Pt 2):337-343
Rybalkin SD, Bornfeldt KE, Sonnenburg WK, Rybalkina IG, Kwak KS, Hanson K, Krebs EG,
Beavo JA (1997) Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C)
is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype.
J Clin Invest 100:2611-2621
Sabrane K, Kruse MN, Fabritz L, Zetsche B, Mitko D, Skryabin BV, Zwiener M, Baba HA,
Yanagisawa M, Kuhn M (2005) Vascular endothelium is critically involved in the hypotensive
and hypovolemic actions of atrial natriuretic peptide. J Clin Invest 115:1666-1674
Satchell SC, Anderson KL, Mathieson PW (2004) Angiopoietin 1 and vascular endothelial growth
factor modulate human glomerular endothelial cell barrier properties. J Am Soc Nephrol
15:566-574
Sayner S, Stevens T (2006) Soluble adenylate cyclase reveals the significance of compartmenta-
lized cAMP on endothelial cell barrier function. Biochem Soc Trans 34:492-494
Sayner SL, Alexeyev M, Dessauer CW, Stevens T (2006) Soluble adenylyl cyclase reveals the
significance of cAMP compartmentation on pulmonary microvascular endothelial cell barrier.
Circ Res 98:675-681
Sayner SL, Frank DW, King J, Chen H, VandeWaa J, Stevens T (2004) Paradoxical cAMP-
induced lung endothelial hyperpermeability revealed by Pseudomonas aeruginosa ExoY. Circ
Res 95:196-203
Seybold J, Thomas D, Witzenrath M, Boral S, Hocke AC, Burger A, Hatzelmann A, Tenor H,
Schudt C, Krull M, Schutte H, Hippenstiel S, Suttorp N (2005) Tumor necrosis factor-alpha-
dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability. Blood
105:3569-3576
Surapisitchat J, Jeon KI, Yan C, Beavo JA (2007) Differential regulation of endothelial cell
permeability by cGMP via phosphodiesterases 2 and 3. Circ Res 101:811-818
Suttorp N, Ehreiser P, Hippenstiel S, Fuhrmann M, Krull M, Tenor H, Schudt C (1996a)
Hyperpermeability of pulmonary endothelial monolayer: protective role of phosphodiesterase
isoenzymes 3 and 4. Lung 174:181-194
Suttorp N, Hippenstiel S, Fuhrmann M, Krull M, Podzuweit T (1996b) Role of nitric oxide and
phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability. Am J Physiol
270:C778-C785
Suttorp N, Weber U, Welsch T, Schudt C (1993) Role of phosphodiesterases in the regulation of
endothelial permeability in vitro. J Clin Invest 91:1421-1428
Takuwa Y (2002) Subtype-specific differential regulation of Rho family G proteins and cell
migration by the Edg family sphingosine-1-phosphate receptors. Biochim Biophys
Acta 1582:112-120
Tsigkos S, Koutsilieris M, Papapetropoulos A (2003) Angiopoietins in angiogenesis and beyond.
Expert Opin Investig Drugs 12:933-941
